医学
关节炎
临床试验
少年
重症监护医学
危害
物理疗法
内科学
心理学
遗传学
社会心理学
生物
作者
Grainne M Murray,Ethan S Sen,Athimalaipet V Ramanan
标识
DOI:10.1016/s2665-9913(20)30426-4
摘要
Treatment for juvenile idiopathic arthritis has undergone substantial changes in recent decades. These changes are partly due to the availability of new treatments, mainly biological agents, as well as developments in treatment strategies, including a focus on concepts such as treat-to-target. In addition, the creation of large paediatric research networks has improved patient access to, and design of, clinical trials for rare paediatric diseases. Although these advances have resulted in improvements in care for most patients with juvenile idiopathic arthritis, certain subgroups of patients continue to have a poor prognosis. Further research aims to identify patients in these subgroups early, to personalise their care, improve functional outcomes, and minimise long-term damage and harm. Optimising the duration of therapy for those individuals who require systemic immunosuppression is also of importance. Incorporation of novel biomarkers in combination with validated clinical measures in an effort to predict outcomes and target therapy accordingly is an exciting development.
科研通智能强力驱动
Strongly Powered by AbleSci AI